← Eichor
Condition: Adenosine Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adenosine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scan
NA · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03331380Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03645460Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Phase 1/Phase 2 · 12 location(s) · Artios Pharma Ltd · NCT05898399Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03685721Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Phase 2 · 13 location(s) · Dana-Farber Cancer Institute · NCT04620187Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
Phase 4 · 1 location(s) · Hsiao-Ying Wey · NCT06763172Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
Phase 3 · 1 location(s) · Rashid Latif Medical College · NCT06717685Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Phase 4 · 2 location(s) · National Institute of Cardiovascular Diseases, Pakistan · NCT07536802The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges
Phase 1 · 1 location(s) · McMaster University · NCT07085975Effects of High Altitude on AMPK Activation
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT02391519Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homo
Phase 1/Phase 2 · 19 location(s) · AstraZeneca · NCT07446855Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions
Phase 4 · 1 location(s) · Weill Medical College of Cornell University · NCT03218137TT-702 in Patients With Advanced Solid Tumours.
Phase 1/Phase 2 · 3 location(s) · Cancer Research UK · NCT05272709Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Phase 2 · 5 location(s) · Gulam Manji · NCT06048484Improvement of Depression With Use of ATP
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06266715Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
Phase 2 · 1 location(s) · Catherine Spina · NCT05915442Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzum
Phase 2 · 152 location(s) · NRG Oncology · NCT05408845Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
Phase 2 · 9 location(s) · Shanghai Gynecologic Oncology Group · NCT052002608-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Le
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05263284Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid T
Phase 1 · 1 location(s) · Chong Kun Dang Pharmaceutical · NCT07215637A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemot
Phase 2 · 3 location(s) · Weill Medical College of Cornell University · NCT05024097Purinergic Compounds in Pseudoxanthoma Elasticum
NA · 2 location(s) · Centre Hospitalier Universitaire de Nice · NCT07323082Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage P
Phase 2/Phase 3 · 1 location(s) · Zhejiang Vimgreen Pharmaceuticals, Ltd. · NCT07725562TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Portage Biotech · NCT04969315A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumo
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05673928PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
Phase N/A · 1 location(s) · University of Iowa · NCT07086560Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Phase 4 · 1 location(s) · Region Skane · NCT06578234Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT05432310Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis
Phase N/A · 1 location(s) · Heart and Diabetes Center North-Rhine Westfalia · NCT04882488Phosphorus-31 Spectroscopy in Phosphate Diabetes
NA · 2 location(s) · Hospices Civils de Lyon · NCT06921720
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.